The forecast for bladder malignant neoplasms mortality among women in the UK remains constant at 5.2 deaths per hundred thousand women from 2024 to 2028. This suggests stability in mortality rates, with no year-on-year change since 2023. Given that there is no variance in the data, this translates to a 0% Compound Annual Growth Rate (CAGR) over the five-year period. In 2023, the rate was also 5.2, consistent with the forecasts.
Future trends to watch for include the impact of new medical treatments and screening programs, which could lead to improvements in early detection and treatment efficacy. Advances in healthcare policies and public awareness campaigns could also influence future mortality trends.
